483
NanoString, A Bruker CompanyNanoString, A Bruker Company – FDA 483, Aug 9, 2024
Record Details
An FDA inspection of NanoString, A Bruker Company, in Seattle, WA, revealed significant deficiencies in the firm's complaint handling procedures. The company failed to adequately maintain complaint files and did not comply with its own standard operating procedures for complaint handling in multiple instances. This included insufficient documentation regarding corrective and preventive actions (CAPA) and assessments for Medical Device Reporting (MDR) requirements.
View Company Profile
ID · caafc536-63a9-4241-b794-735e9947e4bd
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.